Science & Innovation

Pipeline

Dorzagliatin

mGluR5

Poster and Presentation

Peer Reviewed Publications

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information

Corporate Communications

Portfolio Advisory Board

Senior Scientific Advisory Board

About Us

> About Us

> Senior Scientific Advisory Board

Portfolio Advisory Board

Senior Scientific Advisory Board

Media Center

Senior Scientific Advisory Board

Ralph A. DeFronzo, M.D.

<div   id="yc8qeieukum2"   class="clearfix gx_width"><p class="l_c1_jhj_hx fl"><img src="/Public/Uploads/ueditor/upload/image/20190927/1569549685139259.png" alt="l_kylyhx.png"/></p><p class="l_c1_jhjjs fl">Professor and Division Chief of Diabetes Division at the University of Texas Health Science Center</p></div><div   id="yc8qeieukum2"   class="clearfix gx_width"><p class="l_c1_jhj_hx fl"><img src="/Public/Uploads/ueditor/upload/image/20190927/1569549685139259.png" alt="l_kylyhx.png"/></p><p class="l_c1_jhjjs fl">Deputy Director of Texas Diabetes Institute</p></div><div   id="yc8qeieukum2"   class="clearfix gx_width"><p class="l_c1_jhj_hx fl"><img src="/Public/Uploads/ueditor/upload/image/20190927/1569549685139259.png" alt="l_kylyhx.png"/></p><p class="l_c1_jhjjs fl">Led the U.S. development of metformin, and FDA approval in 1995</p></div><div   id="yc8qeieukum2"   class="clearfix gx_width"><p class="l_c1_jhj_hx fl"><img src="/Public/Uploads/ueditor/upload/image/20190927/1569549685139259.png" alt="l_kylyhx.png"/></p><p class="l_c1_jhjjs fl">Discovered a new approach to diabetes treatment that targets glucose reabsorption in the kidneys, which led to the development and approval of SGLT-2</p></div><div   id="yc8qeieukum2"   class="clearfix gx_width"><p class="l_c1_jhj_hx fl"><img src="/Public/Uploads/ueditor/upload/image/20190927/1569549685139259.png" alt="l_kylyhx.png"/></p><p class="l_c1_jhjjs fl">Received several prestigious awards, including the Lilly Award (1987) by the American Diabetes Association, Banting Lectureship Award (1988) by the Canadian Diabetes Association, Novartis Award (2003), ADA’s Albert Renold Award (2002), the ADA’s Banting Award (2008), and the Harold Hamm International Prize (2018)</p></div><div   id="yc8qeieukum2"   class="clearfix gx_width"><p class="l_c1_jhj_hx fl"><img src="/Public/Uploads/ueditor/upload/image/20190927/1569549685139259.png" alt="l_kylyhx.png"/></p><p class="l_c1_jhjjs fl">Published over 800 articles in peer-reviewed medical journals</p></div>

Ji Zhang, Ph.D.

<p>Dr Ji Zhang, Ph.D. in Statistics, previously served as a Senior Vice President of Sanofi Research and Development Operations. He led a global team of more than 4,000 scientists in over 30 countries, and has more than 30 years of experience in innovative drug R&D operations and management in pharmaceutical industry. Dr. Ji Zhang has strategic vision and outstanding operational leadership in clinical development & operations, translational medicine, early development, investment portfolio & project management, digital strategy and implementation. He also has extensive experience in preclinical safety, synthetic and biologic CMC, and medical affairs. He has demonstrated exceptional leadership in transformational changes of enterprises, people development and team building, and global/multi-culture versatility. Dr. Ji Zhang has been extensively published in clinical development research areas with more than 100 peer reviewed scientific papers and technical reports, and has played an important leadership roles in the development and marketing of multiple innovative medicines, including Singulair?, Jevtana?, Multaq?, Toujeo?, Soliqua?, Aubagio?, Dupixent?, Praluent?, Kevzara?, Cerdelga?, Sarclisa?, among others. Dr. Ji Zhang has also achieved industry leading achievements in business model innovation, productivity enhancement and quality control.</p>

Paul Chew, M.D.

About Us

Company Overview

Company History

Leadership Team

Portfolio Advisory Board

Senior Scientific Advisory Board

Partner

Media center

Research & Development

Inovation

Pipeline

Dorzagliatin

mGluR5

Company Publications

Peer Reviewed Publications

Investor Relations

Corporate Governance

Financial Report

Announcements & Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock information

Media

Company News

Media Releases

Video

Careers

Culture

Join Us

Product

HuaTangNing(華堂寧?)

Focus Us

Copyright ? 2024 Hua Medicine (Shanghai) Co., Ltd. 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書編號: （滬）-非經(jīng)營-2022-0079
滬ICP備14036654號-1

滬公網(wǎng)安備 31011502013809號 Privacy Statement Terms of Use

How we use cookies

Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our privacy statement.

Our Science

Science & Innovation

Pipeline

Dorzagliatin

mGluR5

Poster and Presentation

Peer Reviewed Publications

Product

HuaTangNing(華堂寧?)

Investor Relations

Investor Center

Corporate Governance

Financial Report

Announcements and Circulars

Listing Documents

Investor Presentation

IR Contact

Investor Calendar

Stock Information

Corporate Communications

Media

Company News

Media Releases

Video

About Us

Company Overview

Company History

Leadership Team

Partner

Portfolio Advisory Board

Senior Scientific Advisory Board

Media Center

Careers

Company Culture

Join Us

Contact Us

About Us

Senior Scientific Advisory Board